1330
J. Désiré et al.
LETTER
followed by treatment with triphenylphosphine provided
7 in good yield. Finally, dehydration of 7 to imino glucal
2 was accomplished in near quantitative yield upon treat-
ment with oxalyl chloride. Overall, this sequence provides
imino glucal 2 in 8 steps from tri-O-benzyl-D-glucal in
19% overall yield.
References and Notes
(1) (a) Danishefsky, S.J.; Bilodeau, M.T. Angew. Chem. Int. Ed.
Engl. 1996, 35, 1380; (b) Seeberger, P.H.; Haase, W.-C.
Chem. Rev. 2000, 100, 4349.
(2) Three reports have outlined the synthesis of imino glycals. In
the majority of these, they were as formed as by products and
no chemical studies were disclosed, see (a) Natsume, M.;
Wada, M.; Ogawa, M. Chem. Pharm. Bull. 1978, 26, 3364;
(b) Khanna, I.K.; Koszyk, F.J.; Stealey, M.A.; Weier, R.M.;
Julien, J.; Mueller, R.A.; Rao, S.N.; Swenton, L.; Getman,
D.P.; DeCrescenzo, G.A.; Heintz, R.M. J. Carbohydr. Chem.
1995, 14, 843; (c) Fuchss, T.; Streicher, H.; Schmidt, R.R.
Liebigs Ann. Recl. 1997, 7, 1315.
(3) Hetero-exo-glycals have very recently been described, see
Tatibouët, A.; Rollin, P.; Martin, O.R. J. Carbohydr. Chem.
2000, 19, 641.
(4) For a leading reference, see Asano, N.; Nash, R.J.; Molyneux,
R.J.; Fleet, G.W.J. Tetrahedron: Asymmetry 2000, 11, 1645.
(5) For a leading reference, see Duff, F.J.; Vivien, V.; Wightman,
R.H. Chem. Commun. 2000, 2127.
To confirm the stereochemistry at C-5 of imino glucal 2,
and to provide an initial demonstration of its utility in syn-
thesis, we have converted it into the naturally occurring
imino sugar, (+)-fagomine (Scheme 2).6,10 Hydrogenation
of imino glucal 2 using 10% palladium on carbon yielded
piperidine 8, however, it was contaminated with 9-meth-
ylfluorene, produced as a result of the reductive cleavage
of the Fmoc group. To overcome this problem, the hydro-
genation of 2 was executed in the presence of morpholine,
which resulted in the production of the more polar by-
product, 4-fluoren-9-ylmethyl-morpholine, which could
be removed by simple column chromatography. Evidence
in support of the stereochemistry of 8 (and hence 2) was
obtained from nOe experiments performed on 8 and its C-
5 diastereomer 9 (made from 6b in 34% overall yield us-
ing the same reaction sequence). Enhancements were ob-
served between the axial hydrogens H-1, H-3 and H-5 in
8, but not in 9.11 This confirms that the reduction of oxime
5 leads predominately to the desired (6R)-diastereomer 6a
(after Fmoc protection). Finally, hydrogenation of piperi-
dine 8 in the presence of hydrochloric acid effected re-
moval of the benzyl ethers to furnish (+)-fagomine as its
hydrochloride salt. Our synthetic material displayed spec-
troscopic characteristics in good agreement with those re-
ported previously.10,12 Further work to explore the utility
of imino glucal 2 and related compounds is ongoing and
will be disclosed in due course.
(6) Koyama, M.; Sakamura, S. Agr. Biol. Chem. 1974, 38, 1111.
(7) (a) Bettelli, E.; Cherubini, P.; D'Andrea, P.; Passacantilli, P.;
Piancatelli, G. Tetrahedron 1998, 54, 6011; (b) Tius, M. A.;
Busch-Petersen, J. Tetrahedron Lett. 1994, 35, 5181 and
references cited therein.
(8) All new compounds have been fully characterised using
standard spectroscopic and analytical techniques.
(9) (a) Liu, P.S. J. Org. Chem. 1987, 52, 4717; (b) Moutel, S.;
Shipman, M. J. Chem. Soc., Perkin Trans. 1 1999, 1403.
(10) For previous syntheses, see (a) Fleet, G.W.J.; Smith P.W.
Tetrahedron Lett. 1985, 26, 1469; (b) Vonderosten, C.H.;
Sinskey, A.J.; Barbas, C.F.; Pederson, R.L.; Wang, Y.-F.;
Wong, C.-H. J. Am. Chem. Soc. 1989, 111, 3924; (c) Pederson
R.L.; Wong C.-H. Heterocycles 1989, 28, 477; (d) Fleet, G.W.
J.; Witty, D. R. Tetrahedron: Asymmetry 1990, 1, 119;
(e) Effenberger F.; Null, V. Liebigs Ann. Chem. 1992, 1211.
(11) Selected nOe data for 8. Enhancement of H-3 (4.9%) and H-5
(3.7%) from H-1 ; of H-3 (8.2%) from H-5; of H-4 (4.8%)
from H-2 Thus, H-1 , H-3 and H-5 reside on the -face of
the piperidine ring. No nOe's between H-5 and H-3 could be
detected in diastereomer 9.
Fmoc
H
N
N
(12) Selected physical and spectroscopic data: 2 [ ]D20-100 (c 1.0,
CHCl3); max 1715, 1644 cm-1; H (400 MHz; d6-DMSO at
100 °C) 7.82 (2H, d, J 7.6, ArH), 7.60 (2H, t, J 7.7, ArH), 7.37
(2H, m, ArH), 7.31-7.18 (17H, m, ArH), 6.76 (1H, br d, J 8.5,
H-1), 5.07 (1H, ddd, J 8.5, 4.8,1.8, H-2), 4.58-4.46 (7H, m,
H2, Pd/C, morpholine,
EtOH
BnO
BnO
BnO
BnO
5
70%
3
OBn
OBn
8
2
H
H
N
HCl
N
3
OCH2Ph, H-5), 4.35-4.26 (3H, m, CH-Fmoc, CH2-Fmoc),
4.02 (1H, m, H-4), 3.79 (1H, m, H-3), 3.61 (1H, dd, J6,6’ 9.6,
5,6 8.0, H-6), 3.40 (1H, dd, J6’,6 9.6, J6’,5 6.9, H-6'); Found:
H2, Pd/C, HCl,
EtOH
HO
HO
BnO
5
J
85%
BnO
9 (from 6b) OBn
M+NH4+ (ESI), 655.3174. C42H43N2O5 requires 655.3172.
8: [ ]D18+30.5 (c 1.90, CHCl3); H (400 MHz; CDCl3) 7.36-
7.25 (15H, m, ArH), 4.94 (1H, d, J 11.0, OCHHPh), 4.68 (2H,
AB quartet, OCH2Ph), 4.54 (1H, d, J 11.0, OCHHPh), 4.48
(2H, AB quartet, OCH2Ph), 3.72 (1H, dd, J6’,5 2.5, J6’,6 8.9, H-
6'), 3.58 (1H, dd, J6,5 6.1, J6,6’ 8.9, H-6), 3.52 (1H, m, H-3),
3.34 (1H, pseudo t, 9.1, H-4), 3.06 (1H, m, H-1 ), 2.72 (1H,
ddd, J5,6’ 2.5, J5,6 6.1, J5,4 9.1, H-5), 2.57 (1H, dt, J 2.3,12.7, H-
1 ), 2.36 (1H, br s, NH), 2.14 (1H, m, H-2 ), 1.50 (1H, m, H-
2 ); Found: MH+ (ESI), 418.2381. C27H32NO3 requires
418.2382.
3
OH
(+)-fagomine
Scheme 2
Acknowledgement
We are grateful to the Leverhulme Trust and GlaxoSmithKline for
financial support of this project. We are indebted to the EPSRC Na-
tional Mass Spectrometry Service Centre for performing mass spec-
tral measurements and the EPSRC Chemical Database Service at
Daresbury.13
9 [ ]D19-5.0 (c 1.0, CHCl3); H (400 MHz; d6-DMSO) 7.33-
7.26 (15H, m, ArH), 4.55-4.39 (6H, m, 3 OCH2Ph), 3.74
(1H, m, H-3), 3.48 (1H, m, H-4), 3.41 (2H, m, H-6, H-6'), 3.14
(1H, td, J 6.6, 2.2, H-5), 2.74 (1H, m, H-1), 2.66 (1H, m, H-
1'), 1.73 (1H, m, H-2), 1.58 (1H, m, H-2'); Found: MH+ (ESI),
418.2383. C27H32NO3 requires 418.2382.
Synlett 2001, No. 8, 1329–1331 ISSN 0936-5214 © Thieme Stuttgart · New York